LEADER 01677cam0-22003971i-450 001 990001759340403321 005 20191017104852.0 035 $a000175934 035 $aFED01000175934 035 $a(Aleph)000175934FED01 035 $a000175934 100 $a20030910d1991----km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aComunitarizzazione del diritto interno e diritto agrario regionale regime giuridico dei terreni forestali$eatti delle 4. Giornate camerti di diritto agrario comunitario, Camerino, 26-27 ottobre, Lleida, 2-3 novembre 1990$e4., 1990-1991$fa cura di Ezio Capizzano, Augustínrrano$gpresentazione di Ezio Capizzano 210 $a[S. l.$cs. n.]$dstampa1991$eCamerino$gCentro interdipartimentale audiovisivi e stampa dell'Università di Camerino 215 $aXXXII, 803 p.$d24 cm 300 $aIn testa al front.: Università degli studi di Camerino, Facoltà di giurisprudenza (Cattedra di diritto agrario) 610 0 $aDiritto agrario 610 0 $aAgricoltura$aDiritto comunitario 676 $a343.076 676 $a346 702 1$aCapizzano,$bEzio 702 1$aLuna Serrano,$bAgustìn 710 12$aGiornate camerti di diritto agrario comunitario$d<4. ;$f1990 ;$eCamerino-Lleida>$0424500 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990001759340403321 952 $a60 343.076 CAPE 1991$b3479$fFAGBC 952 $aVI G 143$b23376$fFSPBC 952 $a23-B-201$b4794$fDDCP 959 $aFAGBC 959 $aFSPBC 959 $aDDCP 996 $aComunitarizzazione del diritto interno e diritto agrario regionale, regime giuridico dei terreni forestali$9199560 997 $aUNINA LEADER 04351nam 22006135 450 001 9910639885403321 005 20230928195717.0 010 $a3-031-23058-2 024 7 $a10.1007/978-3-031-23058-5 035 $a(CKB)5580000000497082 035 $a(DE-He213)978-3-031-23058-5 035 $a(PPN)267808267 035 $a(MiAaPQ)EBC31054657 035 $a(Au-PeEL)EBL31054657 035 $a(OCoLC)1356794942 035 $a(EXLCZ)995580000000497082 100 $a20230102d2023 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aTherapeutic Applications of Dopamine D3 Receptor Function $eNew Insight After 30 Years Of Research /$fedited by Isabelle Boileau, Ginetta Collo 205 $a1st ed. 2023. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2023. 215 $a1 online resource (VIII, 275 p. 1 illus.) 225 1 $aCurrent Topics in Behavioral Neurosciences,$x1866-3389 ;$v60 311 08$a3-031-23057-4 327 $aPreface -- A Historic Review of the D3 Dopamine System from D3 Cloning to Clinical Trials in Schizophrenia and Drug Addiction -- Location, Location, Location: The Expression of D3 Dopamine Receptors in the Nervous System -- Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor-Receptor Interaction and Striatal Function -- Involvement of DA D3 Receptor and Mitochondrial Functions in Structural Neuroplasticity of the Emotional Brain Circuits: Possible Role in Depression -- Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target -- Dopamine D3 Receptors: A Potential Target to Treat Motivational Deficits in Parkinson?s Disease -- Therapeutic Challenges of Cognitive Dysfunctions in Neuropsychiatric Disorders: Focus on the Dopamine D3 Receptor -- Dopamine D3 Receptor in Stimulant and Opiate Use Disorders -- The Role of D3 Dopamine-Receptors in Nicotine Dependence: A Synthesis of the Pre-Clinical and Clinical Literature -- The Dopamine D3 receptor in Food Addiction -- The Dopamine D3 Receptor Pharmacology and the Therapeutic Use of D3 Receptor Ligands in Schizophrenia -- D3 receptors and Restless Legs Syndrome -- D3 receptors and PET imaging. 330 $aThe CTBN volume Therapeutic Applications of Dopamine D3 Receptor Function reviews the state of the knowledge on the dopamine D3 receptor and its role in human behavior and disease (i.e.: neuropsychiatric illnesses including schizophrenia, mood disorders, Parkinson?s disease, restless legs syndrome, addictions and substance use disorders). The volume is written by leading experts across multidisciplinary areas (imaging, biobehavioral testing and clinical trials, preclinical models / molecular pharmacology) converging on the therapeutic implications / potential of the D3 receptor. The D3 dopamine receptor is a member of the D2-like family of G protein-coupled receptors. It was cloned and characterized almost 25 years ago. A key feature of the D3 dopamine receptor system, which has attracted considerable attention, is its anatomical localization remarkably restricted to the limbic circuitry. This has spurred the hypothesis that D3 involvement could contribute to the pathophysiology of neuropsychiatric disorders (or to some features of neuropsychiatric disorders), including but not limited to psychosis, addictions and substance abuse, mood and movement disorders. 410 0$aCurrent Topics in Behavioral Neurosciences,$x1866-3389 ;$v60 606 $aPharmacology 606 $aNeurosciences 606 $aPsychiatry 606 $aPharmacology 606 $aNeuroscience 606 $aPsychiatry 615 0$aPharmacology. 615 0$aNeurosciences. 615 0$aPsychiatry. 615 14$aPharmacology. 615 24$aNeuroscience. 615 24$aPsychiatry. 676 $a615 676 $a615.78 702 $aBoileau$b Isabelle$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aCollo$b Ginetta$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910639885403321 996 $aTherapeutic Applications of Dopamine D3 Receptor Function$93284864 997 $aUNINA